Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mirati Therapeutics (NQ: MRTX )

68.73 +1.49 (+2.22%)
Streaming Delayed Price Updated: 10:24 AM EDT, Sep 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 112,294
Open 68.74
Bid (Size) 68.52 (5)
Ask (Size) 68.94 (2)
Prev. Close 67.24
Today's Range 68.17 - 69.99
52wk Range 32.96 - 195.99
Shares Outstanding 51,623,193
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
4 Analysts Have This to Say About Mirati Therapeutics
Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
What 4 Analyst Ratings Have To Say About Mirati Therapeutics
Within the last quarter, Mirati Therapeutics (NASDAQ:MRTX) has observed the following analyst ratings: 
Via Benzinga

Performance

YTD
-54.47%
-54.47%
1 Month
-8.56%
-8.56%
3 Month
-1.34%
-1.34%
6 Month
-13.82%
-13.82%
1 Year
-60.87%
-60.87%

More News

Read More
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2022
Via Benzinga
Mirati's Adagrasib Shows Promising Efficacy In KRAS Mutated Colorectal Cancer
Via Benzinga
Mirati Therapeutics: Q2 Earnings Insights
Via Benzinga
10 Analysts Have This to Say About Mirati Therapeutics
Via Benzinga
Healthcare Sector Still Looks Good But Lacks Momentum
Via Talk Markets
Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost
Via Investor's Business Daily
Snap, Meta Platforms, Pinterest And Some Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Whither Small Caps After Fed’s Tough Talk?
Via Talk Markets
Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation?
Via Talk Markets
iRobot, Fox Factory, TripAdvisor And Some Other Big Gainers From Friday
Via Benzinga
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
Via Benzinga
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Via Benzinga
Amgen Touts Early Lumakras Combo Data In KRAS Cancer Settings
Via Benzinga
Biotech ETF Tops in June: 5 Stocks That Outperform
Via Talk Markets
Bear Market Rally Lifts HealthCare Stocks Off Bottom
Via Talk Markets
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Mirati Therapeutics, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Here's What Cramer Has To Say About Zuora, Johnson Controls International And More
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Rises 100 Points; Kiromic BioPharma Shares Spike Higher
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Mid-Day Market Update: Nasdaq Turns Higher; REV Group Shares Plunge
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.